Skip Nav Destination
1-3 of 3
Clin Sci (Lond) (2017) 131 (23): 2795–2805.
Published: 28 November 2017
...Katrina M. Mirabito Colafella; Chrishan S. Samuel; Kate M. Denton Relaxin is increasingly being recognized as a potent vasodilatory and antifibrotic hormone. Given that relaxin is present in the circulation during the luteal phase of the menstrual cycle and during pregnancy, when arterial pressure...
Alessandra Bitto, Natasha Irrera, Letteria Minutoli, Margherita Calò, Patrizia Lo Cascio, Paolo Caccia, Gabriele Pizzino, Giovanni Pallio, Antonio Micali, Mario Vaccaro, Antonino Saitta, Francesco Squadrito, Domenica Altavilla
Clin Sci (Lond) (2013) 125 (12): 575–585.
Published: 02 August 2013
... of VEGF (vascular endothelial growth factor), and impaired vasculogenesis during healing. Experimental evidence suggests that RLX (relaxin) can improve several parameters associated with wound healing. Therefore we investigated the effects of porcine-derived RLX in diabetes-related wound-healing defects...
Clin Sci (Lond) (2013) 124 (1): 41–51.
Published: 07 September 2012
... with these agents, probably due to progressive airway remodelling. Identifying novel therapies that can target airway remodelling and/or airway reactivity may improve symptom control in these patients. We have demonstrated previously that the anti-fibrotic hormone RLN (relaxin) can reverse airway remodelling...